Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

395.12
-2.3400-0.59%
Pre-market: 395.800.6800+0.17%06:41 EDT
Volume:1.40M
Turnover:557.89M
Market Cap:101.31B
PE:28.08
High:403.58
Open:400.00
Low:394.32
Close:397.46
52wk High:519.88
52wk Low:362.50
Shares:256.39M
Float Shares:255.58M
Volume Ratio:0.88
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.07
EPS(LYR):-2.0768
ROE:22.77%
ROA:13.09%
PB:5.90
PE(LYR):-190.26

Loading ...

This Magnificent S&P 500 Dividend Stock Is Down 18% -- Time to Buy?

Motley Fool
·
Yesterday

Bernstein Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 22

2 Beaten-Down Stocks With Incredible Upside Potential

Motley Fool
·
Aug 22

Argus Cuts Price Target on Vertex Pharmaceuticals to $475 From $525

MT Newswires Live
·
Aug 22

Vertex Minerals Updates Securities Issuance Plan

TIPRANKS
·
Aug 21

Vertex Pharmaceuticals to Participate in Upcoming Wells Fargo Healthcare Conference

Reuters
·
Aug 21

Rothschild & Co Redburn Adjusts PT on Vertex Pharmaceuticals to $530 From $560, Maintains Buy Rating

MT Newswires Live
·
Aug 20

Blockchain Stock Trading Platform StableStock Completes Seed Round Funding with Investment from YZi Labs

Blockbeats
·
Aug 20

Vertex Minerals Ltd. Announces Speculative Options Offering

TIPRANKS
·
Aug 20

What's Wrong With Vertex Pharmaceuticals Stock?

Motley Fool
·
Aug 20

Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline

TIPRANKS
·
Aug 18

Vertex Minerals Ltd. Announces Quotation of New Securities on ASX

TIPRANKS
·
Aug 18

Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns

Motley Fool
·
Aug 17

3 Fantastic Growth Stocks to Buy in August

Motley Fool
·
Aug 17

Is This Beaten-Down Stock a Buy on the Dip?

Motley Fool
·
Aug 15

2 Growth Stocks That Are No-Brainer Buys Right Now

Motley Fool
·
Aug 15

Vertex Resource Group Ltd. Demonstrates Resilience Amidst Q2 2025 Challenges

TIPRANKS
·
Aug 15

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2025 Results

Dow Jones
·
Aug 15

Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Aug 15

V2X Announces Board Changes After Vertex Share Sale

TIPRANKS
·
Aug 15